Member Info for biffa

'An existing drug is entering an early clinical trial phase to treat coronavirus'

is the quote from the BBC website after MH statement at No10.

I've just gone through the ClinicalTrials.gov data base for all Phase 1 and Phase 11 Covid 19 trials. I would say 90% give location details as to where the trial is taking place. (So a slight chance that there might be another, but I doubt it)

There are 4 in the UK.

1)Oxford vaccine
2)University College London
3)4D Pharma
4)TD0903 Theravance Biopharma Phase 1, Dublin (Nas ticker TBPH)USA bio company.

It's not the Oxford vacinne or TBPH so every chance it's us. Probably aware of it as he has just signed off on the £5M grant funding.

However, you need to take a look at TBPH!

They announced they were starting Phase 1 trials on the 9th April (in Dublin) and a second RNS on the 23rd April for 1st dosed subject.

On this news alone their Market Cap has increased by $500M (£400M)from $1.4B to $1.9B and it is Phase 1 ffs!

If you read the release it is also targeting the same lung activation as our Phase 11.

Our MCap has increased by SFA.

Interesting times but this is an absolute steal before the market works out what they have missed.

Myles has this as his largest long position in Covid treatment plays so we are in good company.

22nd April RNS.

These Affimer reagents will be characterised by Avacta with the aim of developing a laboratory test for the SARS-COV-2 virus antigen within the next few weeks....... These Affimer binders will also be transferred to Cytiva shortly for implementation in a point-of-care test strip, similar in appearance to a pregnancy test, giving a visual read-out in minutes using a sample such as saliva.

6 days gone already.

The new Lab test could be by the end of the week.

Cytiva will have samples this week.

Possible new partners this week.

The 31M new shares start trading next Friday (24th) so approx 210M total shares.
I assume some have already been sold forward (as I can't see a lock in clause)
Interesting if it gets voted down at the GM, 18p being a bit of a **** take.
Could be VW all over again.

6 other companies today have moved their results back by 3/4 weeks. 4 yesterday.
Sign of the times.
Much prefer them to concentrate on new deals.

GE Health only signed up when they had proof of product.

There are no 'ifs and buts' on this one.

It is coming to market and it will be massive.

On their twitter feed.
Massive coverage.

Test and Trace.
This will be the new mantra, the world over until we have a vaccine.

The share price was doing quite well and rising with the company news flow in Jan/Feb. 30p +

Got hammered with the rest of the market and IP Group being a forced seller.

Point being, the company is worth 60p all day long and that's without the Covid deals.

US investors coming on stream.

USA investors should wake up to the deal on their GE/Cytiva twitter feed.
We also have the Moderna webcast at 8am ET so midday here.
They went all in with us in Feb 19 so you never know?

The deal has finally gone up on the Cytiva (GE Health) twitter page today.
Late Friday night it went up on the GE CV 19 page.

Just buy the shares... and then buy some more.

We were 30p 6 weeks ago.

IP group was a forced seller during the crash and effectively dumped their 15% stake into the market, hence the serious drop.

This news hasn't even begun to filter through.

Wellcome Trust director Sir Jeremy Farrar says the UK is “likely to be one of the worst, if not the worst, affected countries in Europe”.

Sir Jeremy, a member of the UK government's Scientific Advisory Group for Emergencies (Sage), said this was down to the lack of testing and tracing.

He also told the BBC's Andrew Marr a second or third wave of coronavirus was "probably inevitable" and a vaccine was the only way out,

A vaccine could be available by autumn, he added, but it would take months to ramp up manufacturing of it to get to "the scale required to vaccinate many millions of people".

"I would hope we can get done in 12 months," said Sir Jeremy.

From this mornings A Marr show. Wellcome Trust/Sage.

No vaccine anytime soon.
2nd and 3rd wave.
Testing and tracing.

The new normal is the virus.
It's here to stay and the only way anything will start moving again is if we can test and test and test.

They have the reagent that detects the virus and they have one of the biggest pharmas in the world gearing up to mass produce the test.

10 out of 10 on the design front.
Good to see Byotrol front and centre on all their products going forward.
Can't wait to see the RNS!

The EPA has qualified Byotrol24 for use against COVID19. Unfortunately, global demand for Byotrol products is far greater than current manufacturing capacity. At this time we cannot say when Byotrol24 will be available for purchase by the general public. Thank you for your patience and understanding as we work to make Byotrol24 available to everyone.

Byotrol24 face book update on Friday.

First time i've seen them use the word 'global'. Looks like the pan USA deal will include ROW along the lines of the Tistel deal.

https://www.businessweekly.co.uk/news/biomedtech/tristel-alliance-byotrol-targets-hospitals-novel-product

20k shares of Blinkx became 2000 shares in ROne (10 for 1, and price went up tenfold)
1000 Rone became 848 Tap/Trem
Happy to be corrected.

Schroders have actually increased their holding post News Corp deal by approx 275K shares.
Check back to 2oth Dec RNS.
I have no problem with getting rid of sh@t revenue that makes no money.
Sounds like a good way to run a company!?

The TRMR investor page has been updating the Schroder increase for months. Nov 25th being the last update, which has them at 15.3%.
There is approx 4/5% still to be claimed by someone (yesterdays trades and the previous 3 weeks)
I met AB from Schroders at the AGM (11%) and his view was TAP/TRMR was now the company he had always wanted. i.e with Rone/Yume on board the jigsaw was complete. Lombard sold out to Mithaq.
The Uber court case has been kicked down the line to mid January and reading the docs, we have a good chance of it being thrown out by the judge.
Year end trading update around the same time. If anywhere close to forecast we should double next year imho.
BOD have always promised dividend reinstatement so interesting times ahead.